Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Treatment commences in U.K. phase II study of clofarabine for adult AML

Aug. 12, 2004

Quadramet to be investigated in a novel trial in high-risk prostate cancer patients

Aug. 12, 2004

New U.K. phase I study investigates systemic administration of Reolysin

Aug. 12, 2004

New program evaluates Modrenal in pre- and postmenopausal women

Aug. 12, 2004

Novel antimitotic agent circumvents tumor resistance in vivo

Aug. 12, 2004

Human multidrug resistance protein 1 targeted in malignant cells

Aug. 11, 2004

New epothilone derivatives in early development at Novartis

Aug. 11, 2004

Japanese researchers prepare and test a new antineoplastic antibiotic

Aug. 11, 2004

New KDR and FGFR inhibitors with potential in solid tumor therapy

Aug. 11, 2004

Yakult Honsha and Taiho to copromote oxaliplatin in Japan

Aug. 11, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...